Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine

Vaccine

Volumn 18, Issue 20, 2000, Pages 2132-2141

  An, Ling Ling ^a   Rodriguez, Fernando ^a   Harkins, Stephanie ^a   Zhang, Jie ^a   Whitton, J Lindsay ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CTL; DNA immunization; Minigene

Indexed keywords

CD8 ANTIGEN; CYTOKINE; DNA VACCINE; EPITOPE; NEUTRALIZING ANTIBODY; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE; GENETIC CODE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MENGO VIRUS; MINIGENE; MOUSE; NONHUMAN; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; PROTECTION; PROVOCATION TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SPLEEN LYMPHOCYTE; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CODON; CYTOKINES; EPITOPES; GENES, SYNTHETIC; IMMUNITY, CELLULAR; LYMPHOCYTE COUNT; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MENGOVIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PLASMIDS; REGULATORY SEQUENCES, NUCLEIC ACID; RESPIRATORY SYNCYTIAL VIRUSES; RESPIROVIRUS; SPLEEN; TIME FACTORS; VACCINATION; VACCINES, DNA; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL VACCINES; VIRUS REPLICATION;

EID: 0034097666     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00546-0     Document Type: Article

References (43)

1. Tang D.C., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
2. Ulmer J.B., Donnelly J.J., Parker S.E., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
3. Hassett D.E., Whitton J.L. DNA immunization. Trends in Microbiol. 4:1996;307-312.
4. Klavinskis L.S., Whitton J.L., Joly E., Oldstone M.B.A. Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virol. 178:1990;393-400.
5. Del Val M., Schlicht H.J., Volkmer H., Messerle M., Reddehase M.J., Koszinowski U.H. Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. J. Virol. 65:1991;3641-3646.
6. Whitton J.L., Sheng N., Oldstone M.B.A., McKee T.A. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 67:1993;348-352.
7. Thomson S.A., Elliott S.L., Sherritt M.A., et al. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. J. Immunol. 157:1996;822-826.
8. An L.L., Whitton J.L. A multivalent minigene vaccine, containing B cell, CTL, and Th epitopes from several microbes, induces appropriate responses in vivo, and confers protection against more than one pathogen. J. Virol. 71:1997;2292-2302.
9. Yu Z., Karem K.L., Kanangat S., Manickan E., Rouse B.T. Protection by minigenes: a novel approach of DNA vaccines. Vaccine. 16:1998;1660-1667.
10. An L.L., Whitton J.L. Multivalent minigene vaccines against infectious disease. Curr. Opin. Molec. Ther. 1:1999;16-21.
11. Whitton J.L., Tishon A. Use of CTL clones in vitro to map CTL epitopes. Oldstone M.B.A. Animal virus pathogenesis: a practical approach. 1990;104-115 Oxford University Press, Oxford.
12. Burkhart C., Freer G., Castro R., et al. Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus. J. Virol. 68:1994;1573-1580.
13. Kozak M. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J. 16:1997;2482-2492.
14. Kozak M. Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Res. 9:1981;5233-5262.
15. Murali-Krishna K., Altman J.D., Suresh M., et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 8:1998;177-187.
16. + T cells during acute infection with lymphocytic choriomeningitis virus. J. Immunol. 161:1998;3215-3218.
17. Whitmire J.K., Asano M.S., Murali-Krishna K., Suresh M., Ahmed R. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection. J. Virol. 72:1998;8281-8288.
18. + T cells. Nature. 401:1999;76-79.
19. + T cells during an acute virus infection. Immunity. 8:1998;167-175.
20. + T cell-mediated antiviral protection. J. Immunol. 162:1999;2867-2874.
21. Yokoyama M., Zhang J., Whitton J.L. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:1995;2684-2688.
22. Whitton J.L., Oldstone M.B.A. Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes. J. Exp. Med. 170:1989;1033-1038.
23. Jacobs W.R.J., Snapper S.B., Lugosi L., Bloom B.R. Development of BCG as a recombinant vaccine vehicle. Curr. Top. Microbiol. Immunol. 155:1990;153-160.
24. + cytotoxic T cells. J. Exp. Med. 172:1990;1083-1090.
25. Schafer R., Portnoy D.A., Brassell S.A., Paterson Y. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J. Immunol. 149:1992;53-59.
26. Anton L.C., Yewdell J.W., Bennink J.R. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J. Immunol. 158:1997;2535-2542.
27. Rodriguez F., An L.L., Harkins S., et al. DNA immunization with minigenes: low frequency of memory CTL and inefficient antiviral protection are rectified by ubiquitination. J. Virol. 72:1998;5174-5181.
28. Van der Most R.G., Sette A., Oseroff C., et al. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157:1996;5543-5554.
29. Maecker H.T., Umetsu D.T., DeKruyff R.H., Levy S. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via Class II MHC. J. Immunol. 161:1998;6532-6536.
30. Hahn Y.S., Braciale V.L., Braciale T.J. Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product. J. Exp. Med. 174:1991;733-736.
31. Bergman C.C., Tong L., Cua R., Sensintaffar J., Stohlman S. Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J. Virol. 68:1994;5306-5310.
32. + T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope. J. Exp. Med. 176:1992;1335-1341.
33. Del Val M., Schlicht H.J., Ruppert T., Reddehase M.J., Koszinowski U.H. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell. 66:1991;1145-1153.
34. + T cells can be distinguished by their cytokine profiles and phenotypic markers. J Immunol 2000;164:208-16.
35. b restricted subdominant cytoxic T-cell responses in lymphocytic choriomeningitis virus infected mice. Virol. 240:1998;158-167.
36. Van der Most R.G., Concepcion R.J., Oseroff C., et al. Uncovering subdominant cytotoxic T-lymphocyte responses in lynphocytic choriomeningitis virus-infected BALB/c mice. J. Virol. 71:1997;5110-5114.
37. Newmaster R.S., Mylin L.M., Fu T.M., Tevethia S.S. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection. Virol. 244:1998;427-441.
38. + T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination. J. Immunol. 160:1998;2425-2432.
39. Lee A.H., Suh Y.S., Sung J.H., Yang S.H., Sung Y.C. Comparison of various expression plasmid for the induction of immune response by DNA immunization. Mol. Cells. 7:1997;495-501.
40. Chapman B.S., Thayer R.M., Vincent K.A., Haigwood N.L. Effect of intron A from human cytomegalovirus (Towne) immediate- early gene on heterologous expression in mammalian cells. Nucleic Acid Res. 19:1991;3979-3986.
41. Bullock T.N., Eisenlohr L.C. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J. Exp. Med. 184:1996;1319-1329.
42. Bullock T.N., Patterson A.E., Franlin L.L., Notidis E., Eisenlohr L.C. Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression. J. Exp. Med. 186:1997;1051-1058.
43. Ciernik I.F., Berzofsky J.A., Carbone D.P. Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. J. Immunol. 156:1996;2369-2375.